Since the discovery of graphene just over a decade ago, 2D materials have been a central focus of materials research and engineering because of their unique properties and potential of revealing ...intriguing new phenomena. In the past few years, transition metal dichalcogenides (TMDs) have also attracted considerable attention because of the intrinsically opened bandgap. The exceptional properties and potential applications of graphene and TMDs have inspired explosive efforts to discover novel 2D materials. Here, emerging novel 2D materials are summarized and recent progress in the preparation, characterization, and application of 2D materials is highlighted. The experimental realization methods for these materials are emphasized, while the large‐area growth and controlled patterning for industrial productions are discussed. Finally, the remaining challenges and potential applications of 2D materials are outlined.
Recent advances in the growth of novel 2D materials beyond graphene and transition metal dichalcogenides are comprehensively reviewed. The in‐depth and balanced growth methods of these novel 2D materials are presented. The daunting quest for novel 2D materials poses great potential in electronics and other applications.
Summary
Although it is well known that miRNAs play crucial roles in multiple biological processes, there is currently no evidence indicating that milRNAs from Fusarium oxysporum f. sp. lycopersici ...(Fol) interfere with tomato resistance during infection.
Here, using sRNA‐seq, we demonstrate that Fol‐milR1, a trans‐kingdom small RNA, is exported into tomato cells after infection.
The knockout strain ∆Fol‐milR1 displays attenuated pathogenicity to the susceptible tomato cultivar ‘Moneymaker’. On the other hand, Fol‐milR1 overexpression strains exhibit enhanced virulence against the resistant cultivar ‘Motelle’. Several tomato mRNAs are predicted targets of Fol‐milR1. Among these genes, Solyc06g007430 (encoding the CBL‐interacting protein kinase, SlyFRG4) is regulated at the posttranscriptional level by Fol‐milR1. Furthermore, SlyFRG4 loss‐of‐function alleles created using CRISPR/Cas9 in tomato (‘Motelle’) exhibit enhanced disease susceptibility to Fol, further supporting the idea that SlyFRG4 is essential for tomato wilt disease resistance. Notably, our results using immunoprecipitation with specific antiserum suggest that Fol‐milR1 interferes with the host immunity machinery by binding to tomato ARGONAUTE 4a (SlyAGO4a). Furthermore, virus‐induced gene silenced (VIGS) knock‐down SlyAGO4a plants exhibit reduced susceptibility to Fol.
Together, our findings support a model in which Fol‐milR1 is an sRNA fungal effector that suppresses host immunity by silencing a disease resistance gene, thus providing a novel virulence strategy to achieve infection.
See also the Commentary on this article by Thieron et al., 232: 464–467.
Flexible electrochemical energy storage devices have attracted extensive attention as promising power sources for the ever-growing field of flexible and wearable electronic products. However, the ...rational design of a novel electrode structure with a good flexibility, high capacity, fast charge-discharge rate and long cycling lifetimes remains a long-standing challenge for developing next-generation flexible energy-storage materials. Herein, we develop a facile and general approach to three-dimensional (3D) interconnected porous nitrogen-doped graphene foam with encapsulated Ge quantum dot/nitrogen-doped graphene yolk-shell nano architecture for high specific reversible capacity (1,220 mAh g
), long cycling capability (over 96% reversible capacity retention from the second to 1,000 cycles) and ultra-high rate performance (over 800 mAh g
at 40 C). This work paves a way to develop the 3D interconnected graphene-based high-capacity electrode material systems, particularly those that suffer from huge volume expansion, for the future development of high-performance flexible energy storage systems.
To study the mechanisms of relapse in acute lymphoblastic leukemia (ALL), we performed whole-genome sequencing of 103 diagnosis-relapse-germline trios and ultra-deep sequencing of 208 serial samples ...in 16 patients. Relapse-specific somatic alterations were enriched in 12 genes (NR3C1, NR3C2, TP53, NT5C2, FPGS, CREBBP, MSH2, MSH6, PMS2, WHSC1, PRPS1, and PRPS2) involved in drug response. Their prevalence was 17% in very early relapse (<9 months from diagnosis), 65% in early relapse (9-36 months), and 32% in late relapse (>36 months) groups. Convergent evolution, in which multiple subclones harbor mutations in the same drug resistance gene, was observed in 6 relapses and confirmed by single-cell sequencing in 1 case. Mathematical modeling and mutational signature analysis indicated that early relapse resistance acquisition was frequently a 2-step process in which a persistent clone survived initial therapy and later acquired bona fide resistance mutations during therapy. In contrast, very early relapses arose from preexisting resistant clone(s). Two novel relapse-specific mutational signatures, one of which was caused by thiopurine treatment based on in vitro drug exposure experiments, were identified in early and late relapses but were absent from 2540 pan-cancer diagnosis samples and 129 non-ALL relapses. The novel signatures were detected in 27% of relapsed ALLs and were responsible for 46% of acquired resistance mutations in NT5C2, PRPS1, NR3C1, and TP53. These results suggest that chemotherapy-induced drug resistance mutations facilitate a subset of pediatric ALL relapses.
•Chemotherapy-induced mutagenesis may cause drug resistance mutations in ALL, leading to relapse.
•Thiopurines in particular likely cause drug resistance mutations in NT5C2, NR3C1, and TP53.
Display omitted
A ternary polymer memory device based on a single polymer with on‐chain Ir(III) complexes is fabricated by combining multiple memory mechanisms into one system. Excellent ternary memory ...performances—low reading, writing, and erasing voltages and good stability for all three states—are achieved.
Morella rubra, red bayberry, is an economically important fruit tree in south China. Here, we assembled the first high‐quality genome for both a female and a male individual of red bayberry. The ...genome size was 313‐Mb, and 90% sequences were assembled into eight pseudo chromosome molecules, with 32 493 predicted genes. By whole‐genome comparison between the female and male and association analysis with sequences of bulked and individual DNA samples from female and male, a 59‐Kb region determining female was identified and located on distal end of pseudochromosome 8, which contains abundant transposable element and seven putative genes, four of them are related to sex floral development. This 59‐Kb female‐specific region was likely to be derived from duplication and rearrangement of paralogous genes and retained non‐recombinant in the female‐specific region. Sex‐specific molecular markers developed from candidate genes co‐segregated with sex in a genetically diverse female and male germplasm. We propose sex determination follow the ZW model of female heterogamety. The genome sequence of red bayberry provides a valuable resource for plant sex chromosome evolution and also provides important insights for molecular biology, genetics and modern breeding in Myricaceae family.
Desalination devices such as capacitive deionization (CDI) have been developed for many years as an approach to relief freshwater shortage. However, due to the limitation of physical adsorption ...capacity of CDI, the salt removal capacity is unable to reach high value. To enhance the desalination capacity effectively, battery materials are employed to fabricate a dual‐ion electrochemical deionization (DEDI) device. Herein, a binder‐free DEDI system with two free‐standing aerogel electrodes is reported. A Na3V2(PO4)3/graphene hybrid aerogel is used as sodium electrode and a AgCl/graphene hybrid aerogel is used as chloride electrode. With electric current passing through, sodium and chloride ions are released or absorbed by two aerogel electrodes. This system achieves super high desalination capacity, excellent cycling stability, and rapid desalination rate. The desalination capacity is as high as 107.5 mg g−1 after 50 cycles with the current density of 100 mA g−1. The outstanding desalination performance of this system shows a synergistic effect of combining battery materials with graphene for deionization and promises a new potential alternative of future desalination design.
A binder‐free dual‐ion electrochemical deionization device is fabricated with free‐standing Na3V2(PO4)3/rGO aerogel and AgCl/rGO aerogel electrodes. It achieves ultrahigh desalination capacity of 107.5 mg g−1 after 50 cycles.
Novel desalination technologies with high ion removal capacity and low energy consumption are urgently needed to solve the water scarcity problem. Here we report a novel energy efficient dual-ions ...electrochemical deionization (DEDI) system with Ag nanoparticles/reduced graphene-oxide (AgNPs/rGO) as chloride ion Faradaic electrode and NaTi2(PO4)3/reduced graphene-oxide (NTP/rGO) as sodium ion Faradaic electrode. During the intercalation process, the sodium ions and chloride ions in the feed solution will be chemically intercalated into NTP/rGO electrode and AgNPs/rGO electrode, respectively. The DEDI system shows a stable and reversible salt removal capacity of 105 mg g−1 for 50 cycles with applied voltage range of −1.2–1.4 V. More importantly, when applying from 0 V to 1.4 V, although the removal capacity is relatively low (35.8 mg g−1), the energy recovery of this system is higher than 30% and the energy consumption is as low as 0.127 Wh g−1. Considering the brackish water used here is 2500 ppm, the energy consumption can be estimated to be 0.254 Wh L−1 for desalination of brackish water to drinkable water (500 ppm). The excellent performance of this DEDI system has made it a promising commercial technology for desalination of brackish water even seawater in the future.
Circulating exosomal microRNAs (exomiR) have been demonstrated to be novel diagnostic biomarkers for various cancers. In this study, we found that circulating exomiR-1229 levels were significantly ...increased in the serum exosomes of patients with colorectal cancer (CRC) and significantly associated with tumor size, lymphatic metastasis, TNM stage and poor survival. Treatment with siRNA-Drosha, siRNA-ALIX and GW4869 repressed the expression of exomiR-1229 secreted from CRC cells. Both CRC-derived exosomes and exomiR-1229 mimic promoted the tubulogenesis of HUVECs, but transfection with exomiR-1229 inhibitor anta-miR-1229 significantly suppressed tube formation. Subsequently, HIPK2 was identified as a target of exomiR-1229 and responsible for the effect of exomiR-1229 on angiogenesis of HUVECs. ExomiR-1229 inhibited the protein expression of HIPK2, thereby activating VEGF pathway. Finally, anta-miR-1229 effectively inhibited tumor growth and angiogenesis in the nude mouse xenograft model. These results highlighted a novel mechanism of CRC angiogenesis and the biological roles of exomiR-1229.
Hepatitis C virus (HCV) genotype 3, particularly subtype 3b, is increasing in prevalence and distribution in China. This study evaluated the prevalence, regional distribution, clinical ...characteristics, host factors, treatment outcomes, and disease progression of patients with HCV genotype 3 in China.
A 5-year follow-up was preceded by a cross-sectional study. Treatment choices were at the discretion of treating physicians. Estimated infection time to overall-disease-progression (defined by ≥1 of: newly diagnosed cirrhosis; cirrhosis at baseline, Child-Turcotte-Pugh score increased 2 points or more; progression from compensated cirrhosis to decompensated cirrhosis; hepatocellular carcinoma; liver transplantation; or death) was calculated using the Kaplan-Meier method. Cox regression analyses were conducted to evaluate the risk factors for disease progression.
The cross-sectional study enrolled 997 patients, including 91 with HCV genotype 3 infection. Among them, subtype 3b (57.1%) was more dominant than subtype 3a (38.5%). Five hundred and twelve patients were included into the follow-up phase. Among patients analyzed for estimated infection time to overall-disease-progression, 52/304 (17.1%) patients with HCV genotype 1 and 4/41 (9.8%) with HCV genotype 3 (4/26 with genotype 3b, 0/13 with genotype 3a, and 0/2 with undefined subtype of genotype 3) experienced overall-disease-progression. Patients with HCV genotype 3 were younger than those with genotype 1 (mean age: 39.5 ± 8.7 vs. 46.9 ± 13.6 years) and demonstrated more rapid disease progression (mean estimated infection time to overall-disease-progression 27.1 vs. 35.6 years).
HCV genotype 3, specifically subtype 3b, is associated with more rapid progression of liver disease. Further analysis to compare HCV subtype 3a and 3b is needed in high prevalence regions.
NCT01293279, https://clinicaltrials.gov/ct2/show/NCT01293279; NCT01594554, https://clinicaltrials.gov/ct2/show/NCT01594554.
PDF
